<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP08742815B8W1" file="EP08742815W1B8.xml" lang="en" country="EP" doc-number="2142543" kind="B8" correction-code="W1" date-publ="20130703" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORS......................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.40 (30 Jan 2013) -  2999001/0</B007EP></eptags></B000><B100><B110>2142543</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20130703</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>08742815.7</B210><B220><date>20080411</date></B220><B240><B241><date>20091029</date></B241><B242><date>20100331</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>911189 P</B310><B320><date>20070411</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20130703</date><bnum>201327</bnum></B405><B430><date>20100113</date><bnum>201002</bnum></B430><B450><date>20130522</date><bnum>201321</bnum></B450><B452EP><date>20121109</date></B452EP><B480><date>20130703</date><bnum>201327</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07D 471/04        20060101AFI20081106BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  31/519       20060101ALI20081106BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61P  35/00        20060101ALI20081106BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>PYRIDO [2,3-D]PYRIMIDIN-7-ONVERBINDUNGEN ALS INHIBITOREN VON PI3K-ALPHA ZUR BEHANDLUNG VON KREBS</B542><B541>en</B541><B542>PYRIDO [2, 3-D]PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF PI3K-ALPHA FOR THE TREATMENT OF CANCER</B542><B541>fr</B541><B542>COMPOSÉS PYRIDO [2, 3-D]PYRIMIDIN-7-ONE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-ALPHA POUR LE TRAITEMENT DU CANCER</B542></B540><B560><B561><text>WO-A-96/34867</text></B561><B561><text>WO-A-2005/105801</text></B561><B561><text>WO-A-2008/021389</text></B561><B561><text>WO-A1-2007/044698</text></B561><B561><text>US-A1- 2004 009 993</text></B561></B560></B500><B700><B720><B721><snm>BUHR, Chris A.</snm><adr><str>355 Belmont Avenue</str><city>Redwood City, California 94061</city><ctry>US</ctry></adr></B721><B721><snm>BAJJALIEH, William</snm><adr><str>2086 45th Avenue</str><city>San Francisco, California 94116</city><ctry>US</ctry></adr></B721><B721><snm>JOSHI, Anagha Abhijit</snm><adr><str>36340 Easterday Way</str><city>Fremont, California 94536</city><ctry>US</ctry></adr></B721><B721><snm>LARA, Katherine</snm><adr><str>3133 Casa de Campo,  211</str><city>San Mateo, California 94403</city><ctry>US</ctry></adr></B721><B721><snm>MA, Sunghoon</snm><adr><str>802 Spruance Lane</str><city>Foster City, California 94404</city><ctry>US</ctry></adr></B721><B721><snm>MARLOWE, Charles K.</snm><adr><str>636 California Way</str><city>Emerald Hills, California 94062</city><ctry>US</ctry></adr></B721><B721><snm>WANG, Longcheng</snm><adr><str>4294 Wilkie Way, Apt. L</str><city>Palo Alto, California 94306</city><ctry>US</ctry></adr></B721><B721><snm>YEUNG, Bryan K. S.</snm><adr><str>Novartis Institute for Tropical Diseases
10 Biopolis Road
05-01 Chromos</str><city>Chromos 138670</city><ctry>SG</ctry></adr></B721></B720><B730><B731><snm>Exelixis, Inc.</snm><iid>101288191</iid><irf>P114124.EP.01</irf><adr><str>210 East Grand Avenue</str><city>South San Francisco, CA 94080</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Main, Malcolm Charles</snm><iid>101082862</iid><adr><str>Murgitroyd &amp; Company 
Immeuble Atlantis 
55 Allee Pierre Ziller</str><city>06560 Valbonne  - Sophia Antipolis</city><ctry>FR</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20091029</date></B845EP><B845EP><ctry>BA</ctry><date>20091029</date></B845EP><B845EP><ctry>MK</ctry><date>20091029</date></B845EP><B845EP><ctry>RS</ctry><date>20091029</date></B845EP></B844EP><B860><B861><dnum><anum>US2008004753</anum></dnum><date>20080411</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2008127678</pnum></dnum><date>20081023</date><bnum>200843</bnum></B871></B870><B880><date>20100113</date><bnum>201002</bnum></B880></B800></SDOBI>
</ep-patent-document>
